Open Access

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins

  • Authors:
    • Rokas Račkauskas
    • Dachen Zhou
    • Simonas Ūselis
    • Kęstutis Strupas
    • Ingrid Herr
    • Peter Schemmer
  • View Affiliations

  • Published online on: October 11, 2023     https://doi.org/10.3892/or.2023.8646
  • Article Number: 209
  • Copyright : © Račkauskas et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

December-2023
Volume 50 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Račkauskas R, Zhou D, Ūselis S, Strupas K, Herr I and Schemmer P: [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins. Oncol Rep 50: 209, 2023.
APA
Račkauskas, R., Zhou, D., Ūselis, S., Strupas, K., Herr, I., & Schemmer, P. (2023). [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins. Oncology Reports, 50, 209. https://doi.org/10.3892/or.2023.8646
MLA
Račkauskas, R., Zhou, D., Ūselis, S., Strupas, K., Herr, I., Schemmer, P."[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins". Oncology Reports 50.6 (2023): 209.
Chicago
Račkauskas, R., Zhou, D., Ūselis, S., Strupas, K., Herr, I., Schemmer, P."[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins". Oncology Reports 50, no. 6 (2023): 209. https://doi.org/10.3892/or.2023.8646